whereas the combination of nitrile hydratases (NHase)
with amidases first transforms the nitriles toward amides,
followed by the hydrolysis of these amides into carboxylic
acids.8a,b,9
In this paper, both the chemical and enzymatic hydro-
lysis of 1-arylmethyl-2-(2-cyanoethyl)aziridines is inves-
tigated, providing the first synthesis of 3-(aziridin-2-
yl)propionamides by using nitrile hydratases and the
formation of potassium 3-(aziridin-2-yl)propanoates us-
ing potassium hydroxide in EtOH/H2O. These functio-
nalized aziridines were further elaborated into heterocy-
clic systems such as δ-lactams and γ-lactones.
reaction mixtures, in which the target compounds 3-
(aziridin-2-yl)propionamides 2 were present in low yields
(15À45%), due to their further hydrolysis toward 3-
(aziridin-2-yl)propanoates 3 (15À70%), 5-hydroxypiper
idin-2-ones 4 (0À33%), and 4-(aminomethyl)butyrolac-
tones 5 (0À14%) (Table 1). To conclude, treatment of 2-(2-
cyanoethyl)aziridines 1 with KOH in EtOH/H2O for 3 or
6 h results in the formation of a set of reaction products,
rendering this an inefficient route for the synthesis of 2.
Table 1. Hydrolysis of 2-(2-Cyanoethyl)aziridines 1
In continuation of our interest in 2-(ω-cyanoalkyl)-
aziridines as building blocks for the preparation of a wide
variety of amino nitriles4 and amino acid deriva-
tives,5 a new strategy was explored in this work. All
previously described methodologies were based on the
initial ring opening of the aziridine moiety, followed by
transformation of the nitrile functionality into amides,
acids, or amines. In this paper, the reverse strategy is
contemplated, involving initial hydrolysis of the cyano
group without affecting the strained three-membered ring
system. This approach would thus provide a useful entry
into functionalized aziridines such as 2-(ω-carbamoylal-
kyl)- and 2-(ω-carboxyalkyl)aziridines as suitable sub-
strates for further elaboration.
Since aziridines are sensitive to ring opening upon
treatment with acids,6,10 no acid-catalyzed hydrolysis of
the nitrile moiety in 2-(ω-cyanoalkyl)aziridines can be
employed to provide an entry into the corresponding
amides, leaving basic or enzymatic hydrolysis as the only
options. At first, 1-arylmethyl-2-(2-cyanoethyl)aziridines
1, prepared from 2-(bromomethyl)aziridines7 by treat-
ment with R-lithiated trimethylsilylacetonitrile in THF
according to a literature protocol,10 were treated with 5
equiv of KOH in EtOH/H2O (3/1) and heated under
reflux for 3À6 h. These experiments resulted in complex
1 (Ar)
1a (C6H5)
time (h)
2 (%)
3 (%)a
4 (%)a
5 (%)a
6
6
3
6
33
16
45
42
56
70
15
50
12
0
0
14
7
1b (4-MeC6H4)
1c (2-ClC6H4)
1d (2-MeOC6H4)
33
0
8
a Based on 1H NMR and/or LC of the crude reaction mixture.
Nitrile-hydrolyzing enzymes have proven to be excel-
lent tools in organic synthesis and industrial processes
and have been reviewed extensively in the past.8 The main
advantages of enzymatic approaches over chemical trans-
formations are related to the fact that no harsh conditions,
such as the use of concentrated base or acid and elevated
temperatures, are required and the fact that enzymes often
display high levels of chemo- and enantioselectivity. For
instance, nitrile hydratases can selectively transform nitriles
to the corresponding primary amides at neutral pH and
ambient temperature, whereas chemical approaches often
rely on the use of acid conditions and heating under reflux.
Only a few studies have been conducted on the enzymatic
hydrolysis of nitriles containing an aziridine moiety, all
related to the use of 2-cyanoaziridines.9 These reports
showed a good nitrile hydratase activity, and due to the
presence of a highly enantioselective amidase in the whole
cells, one enantiomer was further converted to the corre-
sponding acid, thus lowering the yield of the primary amide.
Up to now, no reports are available dealing with the
selective hydrolysis of aziridinyl nitriles toward the
(4) (a) D’hooghe, M.; Vervisch, K.; Van Nieuwenhove, A.; De
Kimpe, N. TetrahedronLett. 2007, 48, 1771. (b) D’hooghe, M.; Vervisch,
K.; De Kimpe, N. J. Org. Chem. 2007, 72, 7329. (c) Catak, S.; D’hooghe,
M.; Verstraelen, T.; Hemelsoet, K.; Van Nieuwenhove, A.; Ha, H. J.;
Waroquier, M.; De Kimpe, N.; Van Speybroeck, V. J. Org. Chem. 2010,
75, 4530. (d) D’hooghe, M.; Van Nieuwenhove, A.; Van Brabandt, W.;
Rottiers, M.; De Kimpe, N. Tetrahedron 2008, 64, 1064.
€
(5) (a) Vervisch, K.; D’hooghe, M.; Tornroos, K. W.; De Kimpe, N.
€
J. Org. Chem. 2010, 75, 7734. (b) Vervisch, K.; D’hooghe, M.; Tornroos,
K. W.; De Kimpe, N. Org. Biomol. Chem. 2009, 7, 3271.
(6) (a) D’hooghe, M.; Kenis, S.; Vervisch, K.; Lategan, C.; Smith,
P. J.; Chibale, K.; De Kimpe, N. Eur. J. Med. Chem. 2011, 46, 579. (b)
Katagiri, T.; Takahashi, M.; Fujiwara, Y.; Ihara, H.; Uneyama, K. J.
Org. Chem. 1999, 64, 7323. (c) Disadee, W.; Ishikawa, T. J. Org. Chem.
2005, 70, 9399.
(7) (a) De Kimpe, N.; Jolie, R.; De Smaele, D. J. Chem. Soc., Chem
Commun. 1994, 1221. (b) D’hooghe, M.; Waterinckx, A.; De Kimpe, N.
J. Org. Chem. 2005, 70, 227. (c) De Kimpe, N.; De Smaele, D.; Szakonyi,
Z. J. Org. Chem. 1997, 62, 2448.
(8) (a) Banerjee, A.; Sharma, R.; Banerjee, U. C. Appl. Microbiol.
Biotechnol. 2002, 60, 33. (b) Davis, B. G.; Borer, V. Nat. Prod. Rep. 2001,
18, 618. (c) Martinkova, L.; Kren, V. Biocatal. Biotransform. 2002, 20,
73. (d) O’Reilly, C.; Turner, P. D. J. Appl. Microbiol. 2003, 95, 1161. (e)
DiCosimo, R. Nitrilases and Nitrile Hydratases. Biocatalysis in the
Pharmaceutical and Biotechnology Industries; CRC Press: Boca Raton,
FL, 2007; p 1. (f) Kobayashi, M.; Nagasawa, T.; Yamada, H. Trends
Biotechnol. 1992, 10, 402. (g) Shaw, N. M.; Robins, K. T.; Kiener, A.
Adv. Synth. Catal. 2003, 345, 425. (h) Thomas, S. M.; DiCosimo, R.;
Nagarajan, A. Trends Biotechnol. 2002, 20, 238.
(9) (a) Moran-Ramallal, R.; Liz, R.; Gotor, V. Org. Lett. 2007, 9,
521. (b) Moran-Ramallal, R.; Liz, R.; Gotor, V. J. Org. Chem. 2010, 75,
6614. (c) Wang, J.-Y.; Wang, D.-X.; Pan, J.; Huang, Z.-T.; Wang, M.-X.
J. Org. Chem. 2007, 72, 9391. (d) Wang, J.-Y.; Wang, D.-X.; Zheng, Q.-
Y.; Huang, Z.-T.; Wang, M.-X. J. Org. Chem. 2007, 72, 2040.
(10) Vink, M. K. S.; Wijtmans, R.; Reisinger, C.; Van den Berg,
R. J. F.; Schortinghuis, C. A.; Schwab, H.; Schoemaker, H. E.; Rutjes, F.
P. J. T. Biotechnol. J. 2006, 1, 569.
Org. Lett., Vol. 14, No. 1, 2012
107